Hideo Kunitoh

Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer

Toshimi Takano, Yuichiro Ohe, Hiromi Sakamoto et al. · Journal of Clinical Oncology · 2005 · 708 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia

Qing Lan, Chao A. Hsiung, Keitaro Matsuo et al. · Nature Genetics · 2012 · 354 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer

Hideharu Kimura, Kazuo Kasahara, Makoto Kawaishi et al. · Clinical Cancer Research · 2006 · 324 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group

Kaoru Kubota, Koshiro Watanabe, Hideo Kunitoh et al. · Journal of Clinical Oncology · 2004 · 232 citations · Full text

Medicine, Oncology, Pharmacology +13

<i>EGFR</i> Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan

Toshimi Takano, Tomoya Fukui, Yuichiro Ohe et al. · Journal of Clinical Oncology · 2008 · 220 citations

Medicine, Oncology, Pharmacotherapy +14